Personnel

Pharmaceutical company announces appointments to scientific advisory board

Published in Gene Therapy Weekly, August 4th, 2005

KAI Pharmaceuticals, Inc. announced the appointment of scientists and professionals to its newly-expanded scientific advisory board (SAB). These 8 advisory committee members will meet regularly to provide KAI with guidance concerning the advancement of its pipeline of protein kinase C modulators.

The KAI Scientific Advisory Board includes the following:

Daria Mochly-Rosen, PhD, KAI founder and chair of the SAB, George D. Smith Professor of Translational Medicine, professor and chair, Department of Molecular Pharmacology, Stanford University. Mochly-Rosen co-founded KAI Pharmaceuticals in 2002.

Robert Bell, PhD, a venture partner...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Gene Therapy Weekly

Source: Gene Therapy Weekly (2005-08-04)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry